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Abstract: “Long-Dan” is an important traditional Chinese medicinal (TCM) herb used widely for the treatment of inflammation, 
hepatitis, rheumatism, cholecystitis, and tuberculosis. In the Chinese Pharmacopoeia, the roots and rhizomes of four species from 
the genus Gentiana (Gentianaceae) are recorded as the original materials of “Long-Dan”, called Gentianae Radix et Rhizoma. The 
species included G. manshurica, G. scabra, G. triflora and G. rigescens, which are distributed in different areas of China. Though 
iridoid and secoiridoid glucosides were reported as the main constituents in “Long-Dan”, these four different species also resulted 
in different minor components, which may related to their pharmacological activities. Herein, we summarized the herbal textual 
study, distribution, chemical constituents, biological investigation and quality control of the recorded “Long-Dan” origins in  
Chinese Pharmacopoeia during the period 1960 to 2011. 
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Introduction 
“Long-Dan” is a well-known traditional Chinese medicinal 
(TCM) herb commonly used for curing inflammation, hepatitis, 
rheumatism, cholecystitis, and tuberculosis. In the Chinese 
Pharmacopoeia, the roots and rhizomes of four species from 
the genus Gentiana (Gentianaceae), including G. manshurica 
Kitag. (Tiao-Ye-Long-Dan), G. scabra Bge. (Cu-Cao-Long-
Dan, Long-Dan), G. triflora Pall. (San-Hua-Long-Dan) and G. 
rigescens Franch. (Dian-Long-Dan), are recorded as the raw 
materials of “Long-Dan” and called Gentianae Radix et  
Rhizoma.1 These four Gentiana species are distributed in  
different areas of China. Though iridoid and secoiridoid  
glucosides, e.g. loganic acid, gentiopicroside, sweroside and 
swertiamarin were reported as the main constituents, different 
species also resulted in their different minor components. 
Modern pharmacological studies indicated that “Long-Dan” 
had various bioactivities, such as hepatoprotective, anti-
inflammatory, analgesic, anti-proliferative, and anti-microbial 
effects. Owing to these bioactivities and chemical constituents, 
much attention has been paid to different “Long-Dan” species. 
A review described the phytochemicals and biological  
activities of Gentiana species from 1960 to June of 2009,2 
however, no one focused on the recorded “Long-Dan" origins 
in Chinese Pharmacopoeia from various aspects. The present 
article summarized the herbal textual study, distribution,  
phytochemical progress, biological activities, as well as the 
quality control of the four recorded “Long-Dan” origins during 
the period 1960 to 2011. It is hopeful that our crude remark 
may bring out some good idea with the development of new 
strategies for traditional medicine in the future. 
 
1 Herbal Textual Study 
“Long-Dan” has been used as a medicinal herb since ancient 
times. It was firstly recorded on “Shennong Bencao Jing” 
called “Ling-You” from more than 2000 years ago. Several 
variant names, e.g. “Cao-Long-Dan”, “Long-Dan-Cao”, “Ku-
Cao” and “Dan-Cao” had been used and regarded as the  
synonyms of “Long-Dan” in ancient times, according to the 
historical records. All of them were relevant to the bitterness 
of the herb.3 In “Mingyi Bielu”, it recorded that “Long-Dan” 
grew in Shandong province of China, whose roots were picked 
in February, August, November, and December, and dried in 
shade, while “Jiuhuang Bencao” described that “Long-Dan” 
was found in Henan province. “Zhiwu Mingshi Tukao”  
(Illustrated Book on Plants in Qing Dynasty) recorded that 
"Dian-Long-Dan" (G. rigescens) was growing in the  
mountains of Yunnan province.3 Since “Tiao-Ye-Long-Dan” 
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(G. manshurica) was the largest and most widely distributed 
species of “Long-Dan”, it should be the mostly used variety in 
ancient times.4 
The earliest record about the function of “Long-Dan” was in 
“Shennong Bencao Jing”, in which it was characterized by 
bitter in taste and cold in nature. “Mingyi Bielu” described 
“Long-Dan” as innoxious and great cold in nature. About the 
channel tropism, “Long-Dan” was ascribed to the meridian of 
liver, kidney, and urinary bladder in “Leigong Paozhi Yaoxing 
Jie” and remarked by “Yaoxing Jie”. In addition to the  
bitterness, “Long-Dan” also possessed the taste of sour, which 
contributed to the digestion of stomach, as those accounted in 
“Yixue Zhongzhong Canxi Lu”. “Yaoxing Fu” wrote that it 
could remove the heat of liver and the damp-abscess of 
"Xiajiao" concerning of the organs of liver and kidney. In 
“Bencao Gangmu” (Outline Treatise of Medical Herbs,  
compiled by Shi-Zhen Li), “Long-Dan” was recorded to be 
used for the treatment of sore throat and night sweats, while in 
“Depei Bencao”, it was ascribed to cure jaundice, relieve  
diarrhea, and heal bulbar conjunctiva congestion. Chen Shiduo 
noted that “Long-Dan-Cao” was used especially for  
eliminating dampness through diuresis and curing jaundice in 
“Ben-cao Xinbian”.5 
It is noted that the records about the function of “Long-
Dan” in ancient medical books were in accordance with the 
modern clinical application of this herb for curing inflamma-
tion, hepatitis, rheumatism, cholecystitis, and tuberculosis. 
 
2 Distribution 
Among the four original plants (G. manshurica, G. scabra, 
G. triflora, and G. rigescens) of Gentianae Radix et Rhizoma 
in Chinese Pharmacopoeia,, the former three species, are  
mainly distributed in the northeast of China, used to be called 
as “Guan-Long-Dan”, while the last one called as “Dian-Long-
Dan” is mainly growing in the southwest of China, particularly 
in the mountainous areas of Yunnan province.1 
G. manshurica grows in between the edge to the clearings 
of forest, hillsides, roadsides, meadows, and grassland near to 
the cropland with altitude at 200–1700 m. It is mainly  
distributed in northeast of China, and south part of Shandong, 
Shanxi, and Henan province. Some populations are also  
growing in the central part of Shanxi and Hubei provinces, and 
the west regions of Hunan, Guangxi, Guangdong, Jiangxi, and 
Zhejiang provinces.4 
G. scabra could be found mainly in the meadows, forest 
edge, and scrub or river meadow. It is distributed primarily in 
the three Northeast China provinces, the northeastern area of 
Inner Mongolia, and northern regions of Fujian and Zhejiang 
provinces.4 
G. triflora, found in meadows, glade, or shrubs with altitude 
ca. 200–1500 m is mainly distributed in Heilongjiang, Jilin, 
and Inner Mongolia of China.4 
G. rigescens grows in the slopes grass or short grass with al-
titude 800–3000 m. This species is native to Yunnan,  
Sichuan, Guizhou, and the western part of Guangxi province.4 
All of these species were found in the wild with the  
specimen’s picker and pressed for subsequent identification in 
herbaria. However, with the long-term and large-scale  
dredging, wild production of “Long-Dan” was severely  
reduced. Therefore, some Gentiana species have been  
introduced into cultivation, among which G. rigescens and G. 
scabra are two commonly cultivated species in recent years.6,7 
G. rigescens and G. scabra are the main variety in the  
Southwestern and Northeastern herbal markets, respectively. 
 
3 Chemical Constitutions 
A series of iridoids were isolated and characterized as the 
main constituents in “Long-Dan”, together with triterpenes, 
lignans, flavonoids, coumarins, and other types of compounds, 
summarized totally as 96 compounds. Their structures were 
shown below, and their names and the corresponding plant 
sources were organized in Table1. 
 
3.1 Iridoids: As the major chemical constituents, 30  
iridoids (compounds 1–30) were reported from “Long-Dan”. 
Among them, three secoiridoidal glucosides, gentiopicroside 
(1), swertiamarin (2), and sweroside (3), and one iridoidal 
glucoside, loganic acid (23) are not only the four main  
components and active ingredients in “Long-Dan”, but also 
widely distributed in the whole family of Gentianaceae.8 In 
addition, some new iridoids were reported from G. rigescens 
and G. scabra. For example, six new secoiridoid glycosides, 
gentiascabraside A (8) with a methoxyl group occurred at C-
3,9 4'''-O-β-D-glucopyranosyltrifloroside (15),10 4'''-O-β-D-
glucopyranosylscabraside (17),10 and compounds 20–229  
characterized as gentiopicroside with 3–5 additional β-D-
glucopyranosyl moieties attached to the C-6′ of inner  
glucopyranosyl unit, were isolated from the roots and  
rhizomes of G. scabra. Gentiorigenoside A (29), whose C-11 
was esterified with an ethyl group, and C-7 and C-6′ were 
acetylated, was a new secoiridoidal glucoside from the roots 
and rhizomes of G. rigescens.11 
Compared with those from the other Gentiana species, the 
iridoids from the recorded “Long-Dan” origins in Chinese 
Pharmacopoeia were not very diverse, majority gentiopicroside
derivatives (1, 4–6, 8–11, 14, 20–22) and sweroside derivatives
(3, 7, 13, 15–19). Only one kingiside derivative (25), three 
carbocyclic iridoids (23–24, 26) and two secologanic acid 
derivatives (29 and 30) were reported from these recorded 
“Long-Dan” origins, in which four iridoids, gentiopicroside 
(1), swertiamarin (2), sweroside (3), and loganic acid (23) 
were the common chemical composition. The few gentiopicro-
side derivatives, 8–10, oxygenated by OH or OMe at C-3, C-4 
and C-6 positions, should be the typical chemical composition 
of G. scabra. 
 
3.2 Triterpenes: Triterpenes also widely occurred in 
“Long-Dan”.12 To date, 27 triterpenes (31–57) were identified 
from G. rigescens and G. scabra.  
The natural occurrence of chiratane triterpenoids was  
extremely rare. Chirat-17(22)-en-3-one (49), isolated from the 
rhizomes and roots of G. scabra in 2002, was the first example
of a chiratane triterpenoid having a ⊿17(22) double bond.13 Guo 
et al. also reported this kind of compounds from the roots of G. 
scabra in 2011.14 Chirat-16-en-3-one (48) and 17β,21β-
epoxyhopan-3-one (55) possessing a ketone group at C-3, have 
been synthesized in 1990, however, the first isolation of
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Table 1.  Chemical constituents and their plant sources 
No. Compounds Plant sources Parts of plants Ref.
Iridoids 
1 Gentiopicroside G. manshurica Root 44 
G. scabra  Root 45,14
  G. scabra  Rhizomes 10 
  G. triflora  Root 46,47
  G. triflora  Aerial part 48 
  G. rigescens  Root 11,7 
  G. rigescens  aerial part 16 
2 Swertiamarin G. manshurica Root 42 
  G. scabra  Root 43 
  G. triflora  Root 47,50
  G. rigescens Root 7,11 
3 Sweroside G. manshurica  Root 44 
  G. scabra  Root 45 
  G. triflora  Root 47 
  G. rigescens  Root 7,11 
4 6'-O-β-D-Glucosylgentiopicroside G. scabra  Root 51 
  G. triflora  Root 47 
  G. rigescens  Root 11 
5 4'-O-β-D-Glucosylgentiopicroside G. scabra  Root 51 
6 Olivieroside G. scabra  Root 51 
7 8-Hydroxy-10-hydrosweroside G. scabra Root 49 
8 Gentiascabraside A G. scabra Rhizome & root 9 
9 6β-Hydroxyswertiajaposide A G. scabra Rhizome & root 9 
10 Swertiajaposide A G. scabra Rhizome & root 9 
11 Amarogentin G. manshurica  Root 44 
12 Amaroswerin G. manshurica  Root 44 
13 2'-(o,m-Dihydroxybenzyl)sweroside G. scabra Root 45 
  G. triflora  Root 47 
  G. rigescens  Root 7,11 
14 Gentiotrifloroside G. triflora  Root 47 
15 4'''-O-β-D-Glucosyltrifloroside G. scabra  Rhizomes 10 
16 Trifloroside G. scabra  Rhizomes 10 
  G. scabra  Root 49 
  G. triflora  Root 52 
17 4'''-O-β-D-Glucosylscabraside G. scabra  Rhizomes 10 
18 Scabraside G. scabra  Rhizomes 10 
  G. scabra  Root 54 
19 Rindoside G. scabra  Root 53 
20 Scabrans G3  G. scabra  Rhizome & root 9 
21 Scabrans G4  G. scabra Rhizome & root 9 
22 Scabrans G5  G. scabra  Rhizome & root 9 
23 Lognic acid G. scabra  Root 53 
  G. triflora Root 47 
  G. rigescens Root 7,11 
  G. rigescens  Aerial part 16 
24 6'-O-β-D-Glucosylloganic acid G. scabra  Root 55 
  G. rigescens  Aerial part 36 
25 8-Epikingiside G. scabra  Root 55 
26 Gentianaside G. scabra  Root 55 







G. scabra  
G. scabra  







31 Gentirigenic acid G. rigescens  Root 36 
32 Gentirigeoside A G. rigescens  Root 36 
33 Gentirigeoside B G. rigescens  Root 36 
34 Gentirigeoside C G. rigescens  Root 36 
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35 Gentirigeoside D G. rigescens  Root 36 
36 Gentirigeoside E G. rigescens  Root 36 
37 α-Amyrin  G. scabra  Rhizome & root 13 
  G. rigescens  Root 7 
  G. rigescens  Aerial part 16 
38 α-Amyrin palmitate G. scabra  Root 14 
  G. rigescens  Root 7 
  G. rigescens  Aerial part 48 
39 Ursolic acid G. scabra  Aerial part 56 
  G. rigescens  Root 7 
  G. rigescens  Aerial part 16 
40 β-Amyrin G. scabra  Aerial part 56 
  G. rigescens  Root 7 
  G. rigescens  Aerial part 16 
41 β-Amyrin palmitate G. rigescens Root 7 
  G. rigescens  Aerial part 16 
42 β-Amyrin acetate G. scabra  Aerial part 56 
43 Oleanolic acid G. scabra  Root 15 
  G. scabra  Aerial part 56 
  G. rigescens Root 7 
  G. rigescens Aerial part 16 
44 Uvaol 3-O-linoleate G. scabra  Root 57 
45 Uvaol 3-O-stearate G. scabra  Root 57 
46 Erythrodiol 3-O-linoleate G. scabra  Root 57 
47 Erythrodiol 3-O-stearate G. scabra  Root 57 
48 Chirat-16-en-3-one G. scabra  Rhizome & root 13 
49 Chirat-17(22)-en-3-one G. scabra  Rhizome & root 13 
50 Chiratenol G. scabra  Rhizome & root 13 
51 (20S)-Dammara-13(17),24-dien-3-one G. scabra  Rhizome & root 13 
52 (20R)-Dammara-13(17),24-dien-3-one G. scabra  Rhizome & root 13 
53 Lupeol G. scabra  Rhizome & root 13 
  G. rigescens  Root 7 
54 Lupeol palmitate G. rigescens  Root 7 
55 17β,21β-Epoxyhopan-3-one G. scabra  Rhizome & root 13 
56 Hop-17(21)-en-3-one G. scabra  Rhizome & root 13 
57 Hop-17(21)-en-3β-ol G. scabra  Rhizome & root 13 
Lignans 
58 L-Sesamin G. scabra  Root 15 
59 (−)-Syringaresinol-O-β-D-glucoside G. rigescens  Root 20 
60 (−)-Pinoresinol-O-β-D-glucoside G. rigescens  Root 20 
61 Liriodendrin G. rigescens  Root 7,20 
62 (−)-7R,8S-Dehydro-diconiferyl alcohol-4,9'-di-O-β-D-glucoside G. rigescens  Root 20 
63 (−)-7R,8S-Dehydro-diconiferyl alcohol-4-O-β-D-glucoside G. rigescens  Root 20 
64 Lariciresinol-4'-O-β-D-glucoside G. rigescens  Root 20 
65 Tortoside B G. rigescens  Root 20 
Coumarins 
66 Pranfefin G. scabra  Root 15 
Flavanoids 
67 Saponarin G. rigescens  Aerial part 16 
68 Isosaponarin G. rigescens  Aerial part 16 
69 Isoorientin G. rigescens  Aerial part 16 
70 Isoorientin-3'-O-β-D-glucoside G. rigescens  Root 20 
71 Kaempferol G. scabra  Root 15 
Others 
72 Gentiside A G. rigescens  Root 17 
73 Gentiside B G. rigescens  Root 17 
74 Gentiside C G. rigescens  Root 18 
75 Gentiside D G. rigescens  Root 18 
76 Gentiside E G. rigescens  Root 18 
77 Gentiside F G. rigescens  Root 18 
78 Gentiside G G. rigescens  Root 18 
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79 Gentiside H G. rigescens  Root 18 
80 Gentiside I G. rigescens  Root 18 
81 Gentiside J G. rigescens  Root 18 
82 Gentiside K G. rigescens  Root 18 
83 6-Demethoxy-7-methylcapillarisn G. scabra  Aerial part 56 
84 2,3-Dihydroxy benzoic acid methyl ester 3-O-β-D-glucosyl-(1→6)-β-
D-glucoside 
G. rigescens Root 20 
85 2,5-Dihydroxyl benzo5-O-β-D-xylosyl-(1→6)-O-β-D-glucoside G. rigescens  Root 20 
86 4-O-β-D-Glucosyl-glicosyringic acid G. rigescens  Root 7 
87 2-Hydroxy-3-methoxybenzoic acid glucose ester G. scabra  Root 19 
  G. rigescens  Root 20 
88 3,5-Dimethoxy-4-hydroxybenzyl alcohol 4-O-β-D-glucoside G. rigescens  Root 20 
89 Vanillyl alcohol-O-β-D-glucoside G. rigescens  Root 20 
90 4-Hydroxy-3-methoxyphenyl-O-β-D- xylosyl-(1→6)-O-β-D-
glucoside 
G. rigescens  Root 20 
91 3-O-β-D-Glycosylcaffeate G. rigescens  Root 20 
92 Oct-1-en-3-yl arabinosyl-(1→6)-O-β-D- glucoside G. rigescens  Root 20 
93 β-Sitosterol G. scabra  Aerial part 56 
  G. rigescens  Aerial part 16 
  G. rigescens  Root 7 
94 Daucosterol G. scabra  Root 45,14
  G. rigescens  Root 7 
  G. rigescens  Aerial part 16 
95 Cholesterol G. scabra  Root 14 
96 β-Gentiobiose G. rigescens  Root 7 
 
these two compounds from natural source was from G. scabra 
in 2002.13 From the roots of G. rigescens, five new  
dammarane-type triterpenoid glycosides, gentirigeosides A–E 
(32–36), together with new dammarane-type aglycone,  
gentirigenic acid (31), were obtained. It was the first time to 
report triterpenoids with 20S,25-epoxy dammarane skeleton 
from family Gentianaceae.36 
Triterpenes in the four recorded “Long-Dan” origins were 
much diverse. To date, 32 triterpenoids were reported from the 
genus Gentiana,2 including 27 ones from the recorded “Long-
Dan” origins in Chinese Pharmacopoeia. Meanwhile,  
triterpenes from different “Long-Dan” origins showed major 
differences. 20S,25-Epoxy dammaranes were the typical 
triterpenoid components in G. rigescens.36 
 
3.3 Lignans: Compounds 58–65 were lignans derived from 
these four species of “Long-Dan”. These compounds were 
mainly yielded from G. rigescens,7,20 expect that L-sesamin 
(58) was derived from the roots of G. scabra.15 
 
3.4 Coumarins: Compound 66 isolated from the roots of G. 
scabra was the only coumarin in “Long-Dan”. It was separated
and reported from the genus Gentiana for the first time.15 
 
3.5 Flavonoids: To June of 2009, 60 flavonoids were  
identified in the genus Gentiana.2 However, only five ones 
(67–71) were derived from the recorded “Long-Dan” origins 
(G. rigescens and G. scabra). The former four were C-
glycosylflavones16,20, while compound 71 was a flavonol.15 It 
may be due to the different plant parts of ‘Long-Dan”. The 
roots and rhizomes are recorded for medicinal uses of “Long-
Dan”. Flavonoids were chiefly found in the aerial part of G. 
rigescens.16 
 
3.6 Others: Compounds 72–96 were other type of  
compounds from G. rigescens and G. scabra. These  
ingredients comprised alkyl 2,3-dihydroxy-benzoates, phenolic
glycoside, sterols, and disaccharides. 
Gao et al reported a novel class of neuritogenic compounds 
from G. rigescens, namely gentisides A–K (72–82). These 
compounds were potent inducers of neurite outgrowth on 
PC12 cells. Their structure-activity relationships revealed that 
the length of alkyl chain was important for the activity, but the 
structural diversity at the end of the alkyl chain was not.17,18 
As the minor chemical constituents, 2,3-di-hydroxy benzoic 
acid methyl ester 3-O-β-D-glucopyranosyl-(1→6)-β-D-gluco-
pyranoside (84) and 2,5-dihydroxyl benzofuran 5-O-β-D-xylo-
pyranosyl-(1→6)-O-β-D-glucopyranoside (85) were two new 
phenolic glycosides derived from the roots of G. rigescens, 
and compound 84 also showed antifungal activities.20 
 
4 Pharmacological Studies 
4.1 Hepatoprotective Effect: “Long-Dan” is a famous  
hepatic used TCM herb for the treatment of hepatitis. The wa-
ter extracts of G. scabra showed remarkable liver protective 
action by protecting the membranes of hepatocytes, inhibiting 
the immunoreaction occurred in liver, promoting the function 
of phagocytes, or enhancing the treatment for foreign body in 
damaged liver.21 According to the experiment of Wang,  
hepatoprotective effects of G. manshurica against acetamino-
phen-induced acute toxicity were mediated either by prevent-
ing the decline of hepatic antioxidant status or its direct anti-
apoptosis capacity.22 Ethanolic extracts of G. manshurica 
showed protective effects on acute liver injury in mice induced 
by D-GalN and LPS.23 
It’s reported that the basic hepatoprotective ingredient was 
gentiopicroside (1). Gentiopicroside could not only reduce 
liver lipid peroxidation (LPO) of fasted mice and against CCl4-
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induced liver damage, but also offer protection against  
immune-mediated liver damage.24–26 Studies showed that  
gentiopicroside could  decrease the serum ALT and AST  
levels, and increase the liver GSH-Px activity in the mice 
treated with CCl4. It could also promote the secretion of bile 
and increase the concentration of bilirubin in the bile.27,28 
 
4.2 Anti-inflammatory and Analgesic Effects: The  
aqueous extract of Radix Gentianae had a remarkable  
inhibition of picryl chloride (PC) induced contact dermatitis 
and the inhibitory intensity of which was equal to that of  
pred-nisolone at the experimental doses. The extracts, however,
did not influence both inflammatory reactions induced by  
xylene in ear and egg white in footpad.29 Comparison analyzes 
on pharmacological function of the aerial and underground 
parts of Radix Gentianae showed that the anti-inflammation 
effect of aerial part was better than that of the underground 
one.30 The essential oils of G. scabra exhibited a good  
performance of inhibiting NO production and xylene-induced 
ear edema in mice with a dose-dependent manner.31 Ethanolic 
extract of “Guan-Long-Dan” showed anti-inflammatory and 
analgesic effects,32 can protect the lung by inhibiting the  
expression of COX-2, reducing the production of PGE2 and 
promoting the generation of IL-10, in curing acute lung injury 
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Fig. 1.  Iridoids from “Long-Dan” 
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inhibit the auricular edema and decrease the permeability of 
celiac blood capillary, but also reduce the paw swelling  
induced by carrageenan and zymosan A.34 
 
4.3 Antiproliferative Effecs: The water extracts of G. 
scabra had inhibitory effects on sarcoma 180 in mice.35 Two 
compounds, chirat-16-en-3-one (48) and chiratenol (50), from 
G. scabra showed moderate anti-tumor effect against Hela and 
HepG-2 lines.13 
 
4.4 Antimicrobial Effects: 2,3-Dihydroxy benzoic acid  
methyl ester 3-O-β-D-glucopyranosyl-(16)-β-D-gluco-
pyranoside (84) showed inhibitory activities against the 
growth of the plant pathogen Peronophythora litchi and  
Glorosprium musarum.20 The triterpenoid glycosides,  
gentirigeosides A (32), C (34), and E (36) displayed antifungal 
activity against the plant pathogen Glomerella cingulata.36 
While experimental results showed that the aerial parts and the 
underground part of Gentiana spp. inhibited the growth of 
Escherichia coli, Staphylococcus aureus, and Proteus in  
different degrees.30 
 
4.5 Other Effects: It was reported that 2-hydroxy-3-
  
Fig. 2.  Triterpenes from “Long-Dan” 
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methoxybenzoic acid glucosyl ester (87) could prevent mice 
from the PAF-induced death at a dose of 300 μg.19 Gentisides 
A–K (72–82) from G. rigescens induced the growth of PC12 
cells. Among them, gentiside C (74) showed a significant  
neuritogenic activity at 1 μM against PC12 cells comparable to 
that seen for the best nerve growth factor (NGF) at a  
concentration of 40 ng/mL. While gentiside C possessing the 
shortest alkyl chain length exhibiting the highest neuritogenic 
activity among all of the gentisides indicated that the length of 
the alkyl chain was important for the activity.17,18 
G. triflora polysaccharide enhanced thymus index and 
spleen swelling index, increased carbon clearance index, and 
significantly higher HC50, thus enhancing the specific and 
non-specific immune function of mice.37 What’s more “Long-
Dan” was also used in the treatment of hypothyroid  
conditions.38 
5 Quality Control 
The experimental results demonstrated that gentiopicroside 
was the main effective components of “Long-Dan”, therefore 
it ought to be the most important index in evaluating the quality
of these herbs. The Chinese Pharmacopoeia requires that the 
content of gentiopicroside should be not less than 2%.1  
Thin-layer-chromatography (TLC), reverse phase high-
performance liquid chromatography (Rp-HPLC), high  
performance capillary electrophoresis (HPCE) methods etc., 
have been used for the determination of the content of  
gentiopicroside in these herbs.39–41 It’s reported that there were 
many factors influencing the quality control of “Long-Dan”, 
such as species, growing place, growing periods, collecting 
season, processing and storing, etc.26,42 According to the 
HPLC analysis of Jiang et al, the content of gentiopicroside in 
“Long-Dan” from different growing places ranged from 0.89% 
to 6.47% with an average of 2.97%. G. triflora possessed the 
highest content (6.47%) of gentiopicroside in all the samples 
and content in G. manshurica, G. scabra, and G. rigescens 
were 4.19%, 2.31%, and 6.28%, respectively. Wei et al.  
determined the content of gentiopicroside in 38 samples of 
Radix Gentianae from different habitat and the results indicated
that the content of gentiopicroside varied considerably from 
place to place.43 Thus, it should be combined all the factors to 
give a rational quality evaluation of “Long-Dan”. 
 
6 Concluding Remarks 
Four different Gentiana species distributed in different  
areas of China have been recorded in the Chinese  
Pharmacopoeia to be used as the original plants of “Long-
Dan”. Though gentiopicroside together with swertiamarin, 
sweroside, and loganic acid, was the major component,  
different origins resulted in different minor constituents. So far, 
a large number of phytochemical studies have been carried on 
G. scabra and G. rigescens, however, it still remains to be 
exploited for the chemical constituents of G. manshurica and 
G. triflora. Previous reports on G. scabra and G. rigescens 
yielded the similar main chemical components. However,  
different minor compounds were also identified. Modern 
pharmacological researches on these four different species 
demonstrated the significant hepatoprotective effect of “Long-
Dan” and other bioactivities, which are coincide with modern 
clinical application, while the bioactivities of minor  
constituents were pressing for research to get more different 
properties of these four different origins. Therefore, it needs 
more work on the chemical and pharmacological comparison 
of the original plants of “Long-Dan”, especially those of G. 
manshurica and G. triflora. Whether the minor constituents 
exert any appreciable influence on the pharmacological  
activities, it should be further studies on, especially the  
discrepant chemical constituents. In brief, we should pay much 
attention and attach more importance to these traditional  
Chinese medicines, which have been used widely, but have 
more than one origin, and integrate various new technologies 
into traditional medicine research in the future studies, in  
order to understand them comprehensively and utilize them 
reasonably and scientifically. 
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